MX2011008398A - Lactobacillus helveticus cncm i-4095 y el control del peso. - Google Patents

Lactobacillus helveticus cncm i-4095 y el control del peso.

Info

Publication number
MX2011008398A
MX2011008398A MX2011008398A MX2011008398A MX2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A MX 2011008398 A MX2011008398 A MX 2011008398A
Authority
MX
Mexico
Prior art keywords
lactobacillus helveticus
weight control
helveticus cncm
present
obesity
Prior art date
Application number
MX2011008398A
Other languages
English (en)
Inventor
Catherine Mace
Christian Darimont-Nicolau
Fabrizio Arigoni
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011008398A publication Critical patent/MX2011008398A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

En general, la presente invención se refiere al campo de la obesidad. En particular, la presente invención se refiere al uso de probióticos para apoyar el manejo del peso y para tratar o prevenir la obesidad. Una modalidad de la presente invención se refiere al uso del Lactobacillus helveticus CNCM I-4095 para la preparación de una composición para apoyar el manejo del peso, promover la pérdida de peso y/o para tratar la obesidad.
MX2011008398A 2009-02-10 2010-02-04 Lactobacillus helveticus cncm i-4095 y el control del peso. MX2011008398A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09152434A EP2216034A1 (en) 2009-02-10 2009-02-10 Lactobacillus helveticus CNCM I-4095 and weight control
PCT/EP2010/051360 WO2010091991A1 (en) 2009-02-10 2010-02-04 Lactobacillus helveticus cncm i-4095 and weight control

Publications (1)

Publication Number Publication Date
MX2011008398A true MX2011008398A (es) 2011-09-01

Family

ID=40749130

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008398A MX2011008398A (es) 2009-02-10 2010-02-04 Lactobacillus helveticus cncm i-4095 y el control del peso.

Country Status (8)

Country Link
US (1) US8454949B2 (es)
EP (2) EP2216034A1 (es)
CN (1) CN102316882B (es)
AU (1) AU2010213007B2 (es)
BR (1) BRPI1008355A2 (es)
CL (1) CL2011001939A1 (es)
MX (1) MX2011008398A (es)
WO (1) WO2010091991A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control
RU2453593C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus helveticus, используемый для получения продукции, содержащей лактобактерии
CN102329762A (zh) * 2011-11-01 2012-01-25 内蒙古农业大学 一种瑞士乳杆菌h9及其用途
CN102329763A (zh) * 2011-11-01 2012-01-25 内蒙古农业大学 一种瑞士乳杆菌h9及其在制备发酵乳中的用途
EP3461477B1 (en) 2012-03-29 2021-06-30 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
CN105074457B (zh) * 2013-03-28 2019-05-17 雀巢产品技术援助有限公司 作为用于预防重量增加的益生元功效的生物标记物的α-酮-异戊酸
CN104771416B (zh) * 2014-01-10 2020-11-10 景岳生物科技股份有限公司 用于控制体重的罗伊氏乳杆菌gmnl-263组合物及其用途
KR102125548B1 (ko) 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
WO2018136884A1 (en) * 2017-01-23 2018-07-26 The Regents Of The University Of California Compositions and methods for treating obesity and inducing weight loss
CN109112083B (zh) * 2018-08-01 2020-08-04 江南大学 一种高产辛酸的瑞士乳杆菌及其应用
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
KR102495246B1 (ko) * 2022-08-02 2023-02-14 (주)헥토헬스케어 체지방 감소 활성을 갖는 락토바실러스 헬베티쿠스 bcc-lh-04 및 이를 포함하는 조성물
CN117757702B (zh) * 2024-02-21 2024-07-16 中科微智(北京)生物科技有限公司 一株瑞士乳杆菌及其在控制血糖中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207948A (pt) * 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
ITMI20020399A1 (it) * 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
EP1388295A1 (en) * 2002-08-07 2004-02-11 Nestec S.A. Cereal based food product comprising DHA
DE602006004956D1 (de) * 2006-02-20 2009-03-12 Gervais Danone Sa Neue Stämme von Lactobacillus helveticus
JP2007284360A (ja) 2006-04-13 2007-11-01 Mitsukan Group Honsha:Kk 乳酸菌由来のppar依存的遺伝子転写活性化組成物
EP2062587A4 (en) 2006-09-04 2013-08-28 Megmilk Snow Brand Co Ltd AGENT FOR ACCELERATING THE INCREASE IN AND / OR PREVENTING DECREASE IN THE LEVEL OF ADIPONECTIN IN BLOOD, AND INHIBITOR OF VISCERAL FAT ACCUMULATION
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP2216034A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus helveticus CNCM I-4095 and weight control

Also Published As

Publication number Publication date
AU2010213007A1 (en) 2011-08-25
WO2010091991A1 (en) 2010-08-19
US8454949B2 (en) 2013-06-04
CL2011001939A1 (es) 2012-01-20
CN102316882A (zh) 2012-01-11
EP2216034A1 (en) 2010-08-11
CN102316882B (zh) 2013-09-18
US20110293568A1 (en) 2011-12-01
BRPI1008355A2 (pt) 2016-02-23
AU2010213007B2 (en) 2014-08-07
EP2396013A1 (en) 2011-12-21

Similar Documents

Publication Publication Date Title
MX2011008398A (es) Lactobacillus helveticus cncm i-4095 y el control del peso.
MX2011008400A (es) Lactobacillus rhamnosus cncm i-4096 y el control del peso.
MX2011008399A (es) Lactobacillus rhamnosus ncc4007, una mezcla probiotica y el control del peso.
MY155516A (en) Lactobacillus rhamnosus and weight control
MX2012003612A (es) Bifidobacterium longum atcc baa-99 (bl999) y control de peso.
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
PL2626076T3 (pl) Zastosowania terapeutyczne Lactobacillus salivarius LS01 DSM 22775
PL2498789T3 (pl) Probiotyczny szczep bifidobacterium
GB2460781B (en) Probiotic bifidobacterium strains
GB2465051B (en) Probiotic bifidobacterium strains
MY156849A (en) Novel lactobacillus plantarum and composition comprising the same
PT2332520T (pt) Lactobacillus paracasei para tratar os pontos de senescência e/ou melasma
SG175167A1 (en) Growing up milks containing probiotic micro-organisms
MX350234B (es) Compuestos de enlace especificos de bacterias gram-positivas.
PL2475764T3 (pl) Niezdolny do przeżycia materiał otrzymany z probiotyku do zapobiegania i leczenia alergii
PL2485743T3 (pl) Szczepy Lactobacillus plantarum jako czynniki hipocholesterolemiczne
PL2753687T3 (pl) Szczepy bakterii kwasu mlekowego i/lub bifidobakterii hamujących/zmniejszających wzrost różnych biotypów E. coli i różnych biotypów bakterii z rodzaju Clostridium
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
MY158310A (en) Prevention and treatment of allergic diarrhoea
PL2568815T3 (pl) Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei
MX2015005898A (es) Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo.
AP2012006139A0 (en) Composition comprising strains of lactobacillus fermentum.
MX346332B (es) Cepas probioticas para aumentar la resistencia transepitelial.
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
MX350212B (es) Nueva cepa de l.bulgaricus con capacidad de inhibir la adhesion de cepas de h. pylori a celulas epiteliales.

Legal Events

Date Code Title Description
FG Grant or registration